Want to see PAYS full AI Analyst Report?
PAYS Stock Chart & Stats
$8.69
$0.19(2.19%)
At close: 4:00 PM EDT
$8.69
$0.19(2.19%)
Day’s Range― - ―
52-Week Range$3.08 - $9.49
Previous CloseN/A
Volume152.25K
Average Volume (3M)554.91K
Market Cap
$512.10M
Enterprise Value$186.45
Total Cash (Recent Filing)$20.55M
Total Debt (Recent Filing)$5.92M
Price to Earnings (P/E)47.0
Beta1.68
Next Earnings
Aug 05, 2026EPS Estimate
0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.19
Shares Outstanding55,905,773
10 Day Avg. Volume537,909
30 Day Avg. Volume554,912
Financial Highlights & Ratios
PEG Ratio0.39
Price to Book (P/B)5.78
Price to Sales (P/S)3.42
P/FCF Ratio5.47
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$9.50Price Target Upside9.32% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)0.24
Revenue Forecast (FY)$108.55M
Bulls Say, Bears Say
Bulls Say
Free Cash Flow StrengthSustained, high free cash flow provides durable funding for organic growth, program onboarding, and potential M&A or shareholder returns. FCF roughly matches net income (0.91x TTM), indicating earnings quality and long-term flexibility if the company sustains current generation levels.
Revenue & Margin ExpansionMaterial top-line growth paired with a profitability inflection shows scalable unit economics and operating leverage. The step-up from losses to double-digit margins demonstrates structural improvements in cost control and pricing mix that can sustain higher incremental profits as revenue scales.
Pharma/Patient Affordability MomentumRapid expansion in pharma programs diversifies higher-margin revenue and deepens competitive moats via payer/vendor relationships. Growing deployed assistance and a robust pipeline suggest durable recurring fee streams and a runway to scale program adds, supporting long-term revenue mix improvement.
Bears Say
Large Asset Base Vs EquityA sizable asset base relative to equity (driven by program balances and restricted funds) increases sensitivity to working-capital swings and operational disruptions. This structure can magnify cash-flow volatility and requires disciplined liquidity management over the medium term.
SaaS/App Execution RiskPlanned product expansion into SaaS represents strategic diversification, but regulatory engagement and no clear timeline create execution risk. Delays could postpone expected revenue diversification and margin benefits, leaving the company more reliant on existing, potentially cyclical segments.
Plasma Center & Customer ConcentrationConcentration in plasma customers and recent center closures/sales create operational and revenue volatility. Losses or churn from a few large customers can materially affect recurring processing volumes and cash generation, elevating medium‑term execution risk until client diversification improves.
Paysign News
PAYS FAQ
What was Paysign, Inc.’s price range in the past 12 months?
Paysign, Inc. lowest stock price was $3.08 and its highest was $9.49 in the past 12 months.
What is Paysign, Inc.’s market cap?
Paysign, Inc.’s market cap is $512.10M.
When is Paysign, Inc.’s upcoming earnings report date?
Paysign, Inc.’s upcoming earnings report date is Aug 05, 2026 which is in 4 days.
How were Paysign, Inc.’s earnings last quarter?
Paysign, Inc. released its earnings results on May 12, 2026. The company reported $0.09 earnings per share for the quarter, beating the consensus estimate of $0.07 by $0.02.
Is Paysign, Inc. overvalued?
According to Wall Street analysts Paysign, Inc.’s price is currently Undervalued.
Does Paysign, Inc. pay dividends?
Paysign, Inc. does not currently pay dividends.
What is Paysign, Inc.’s EPS estimate?
Paysign, Inc.’s EPS estimate is 0.06.
How many shares outstanding does Paysign, Inc. have?
Paysign, Inc. has 55,905,773 shares outstanding.
What happened to Paysign, Inc.’s price movement after its last earnings report?
Paysign, Inc. reported an EPS of $0.09 in its last earnings report, beating expectations of $0.07. Following the earnings report the stock price went down -12.331%.
Which hedge fund is a major shareholder of Paysign, Inc.?
Currently, no hedge funds are holding shares in PAYS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Paysign Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$9.50 (9.32% Upside)
$9.50 (9.32% Upside)
Blogger Sentiment
Bullish
PAYS Sentiment 60%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 3.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $141.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 2.5%
Last 30 Days ▼ 2.5%
Technicals
SMA
Positive
20 days / 200 days
Momentum
1.51%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
52.46%
Trailing 12-Months
Company Description
Paysign, Inc.
PaySign, Inc. (PAYS) is a U.S.-based financial technology company in the payments and prepaid card sector. The company provides payment solutions centered on prepaid debit card programs, including card issuance and program management services, with a focus on corporate/rebate and healthcare-related disbursements.
PAYS Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call highlighted a very strong quarter: substantial revenue and profit growth, wide margin expansion, a robust pharma pipeline, and continued plasma revenue expansion and cash generation. Management reiterated confident full-year guidance and plans to exceed prior program-addition performance. Key risks discussed include a lower-than-guided plasma center count (due to sales/closures), the SaaS/app not yet producing revenue (FDA engagement ongoing), a higher effective tax rate, and margin variability driven by seasonal mix. Overall the positives (large percentage growth across revenue, EBITDA, operating margin, patient assistance dollars, and pipeline strength) substantially outweigh the operational and timing-related lowlights.View all PAYS earnings summariesPAYS Stock 12 Month Forecast
Average Price Target
$9.50
▲(9.32% Upside)
Technical Analysis
International Money Express
―
Repay Holdings
―
AvePoint
―
Payoneer
―
Bakkt Holdings, Inc. Class A
―
Ownership Overview
19.21% Insiders
7.42% Mutual Funds
0.41% Other Institutional Investors
64.19% Public Companies and
Individual Investors